- Home
- RERE vs BVS Comparison
RERE vs BVS Comparison
Compare RERE & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RERE
- BVS
- Stock Information
- Founded
- RERE 2011
- BVS 2011
- Country
- RERE China
- BVS United States
- Employees
- RERE N/A
- BVS N/A
- Industry
- RERE Other Specialty Stores
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RERE Consumer Discretionary
- BVS Health Care
- Exchange
- RERE Nasdaq
- BVS Nasdaq
- Market Cap
- RERE 678.4M
- BVS 656.9M
- IPO Year
- RERE 2021
- BVS 2021
- Fundamental
- Price
- RERE $2.14
- BVS $7.82
- Analyst Decision
- RERE
- BVS Strong Buy
- Analyst Count
- RERE 0
- BVS 4
- Target Price
- RERE N/A
- BVS $15.00
- AVG Volume (30 Days)
- RERE 1.0M
- BVS 339.2K
- Earning Date
- RERE 05-19-2025
- BVS 05-06-2025
- Dividend Yield
- RERE N/A
- BVS N/A
- EPS Growth
- RERE N/A
- BVS N/A
- EPS
- RERE N/A
- BVS N/A
- Revenue
- RERE $2,237,042,920.00
- BVS $573,280,000.00
- Revenue This Year
- RERE $29.57
- BVS N/A
- Revenue Next Year
- RERE $24.43
- BVS $6.09
- P/E Ratio
- RERE N/A
- BVS N/A
- Revenue Growth
- RERE 25.93
- BVS 11.89
- 52 Week Low
- RERE $1.53
- BVS $3.90
- 52 Week High
- RERE $3.70
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- RERE 26.24
- BVS 37.22
- Support Level
- RERE $2.12
- BVS $7.56
- Resistance Level
- RERE $2.40
- BVS $8.66
- Average True Range (ATR)
- RERE 0.21
- BVS 0.61
- MACD
- RERE -0.06
- BVS -0.05
- Stochastic Oscillator
- RERE 2.11
- BVS 28.40
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.